share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bozic Carmen

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bozic Carmen

福泰制药 | 4：持股变动声明-高管 Bozic Carmen
美股sec公告 ·  06/13 16:15
Moomoo AI 已提取核心信息
Carmen Bozic, EVP and CMO of Vertex Pharmaceuticals Inc. (VRTX), completed a sale of 2,280 shares of common stock on June 12, 2024. The transaction was carried out in the open market with the shares sold at a price of $478.00 each, resulting in a total sale value of $1,089,840. Following the sale, Bozic's direct holdings in the company amount to 32,379 shares of common stock.
Carmen Bozic, EVP and CMO of Vertex Pharmaceuticals Inc. (VRTX), completed a sale of 2,280 shares of common stock on June 12, 2024. The transaction was carried out in the open market with the shares sold at a price of $478.00 each, resulting in a total sale value of $1,089,840. Following the sale, Bozic's direct holdings in the company amount to 32,379 shares of common stock.
Vertex Pharmaceuticals Inc.(VRTX) 的执行副总裁兼首席市场官Carmen Bozic于2024年6月12日完成了一笔2,280股普通股的交易。该交易是在公开市场进行的，每股售价为478.00美元，总销售价值为1,089,840美元。本次交易后，Bozic在公司的直接持股数量为32,379股普通股。
Vertex Pharmaceuticals Inc.(VRTX) 的执行副总裁兼首席市场官Carmen Bozic于2024年6月12日完成了一笔2,280股普通股的交易。该交易是在公开市场进行的，每股售价为478.00美元，总销售价值为1,089,840美元。本次交易后，Bozic在公司的直接持股数量为32,379股普通股。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息